Zooca develops health and nutrition products for both animals and humans from the marine resource “Calanus finmarchicus” (copepod).
We are extremely satisfied with the work we have had done at Biotep. There, we were able to both develop and produce the ingredients for our products in an economically sound manner, while simultaneously developing the market. This way, we were able to avoid tying up resources in our own infrastructure during a very costly commercialization phase.
Alice Pedersen, Head of Human Health and Nutrition, Zooca.
Marealis is a biotechnology company that has developed a blood pressure-regulating peptide concentrate from shrimp shells.
Biotep is a flexible pilot facility that has enabled us to pursue market development without incurring the enormous financial risk associated with building our own production plant. Together with Biotep’s skilled process engineers, we have implemented important measures and interventions in production, which allowed us to multiply our production capacity, leading to a much more cost-effective production.
Andreas Semmingsen, CEO, Marealis AS.
